GLP-1 drugs like Ozempic, Wegovy, and Zepbound can slash weight by 15 to 25 percent
If pain becomes severe or persistent, evaluation for other causes like gallstones becomes necessary, as rapid weight loss increases cholecystitis risk
At 2.5mg weekly, a single 10mg vial supports four weeks of research
Diabetes mellitus is one of the major risk factor for CAD and other risk factors for CAD are hypertension, obesity, smoking and dyslipoproteinemias [2]
GLP-1RAs may have direct beneficial effects on oxidative stress because the cAMPPKA pathway evoked by GLP-1RAs inhibited the NAD(P)H oxidasederived oxidative stress generation [33, 34]
Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial